Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed that men with anogenital warts had higher prevalence of HPV6/11 in their regional hair samples compared to healthy controls, and patients with HPV6/11-positive hairs were more likely to have visible warts at subsequent visits.

This case report of an infant with IPEX syndrome highlights the importance of early recognition and treatment, as the patient experienced severe symptoms and succumbed before stem cell transplantation.

In this study, autopsies of children who suffered fatal abuse revealed stress-associated markers like telogen effluvium and thymus involution, which may help pathologists identify chronic abuse cases.

This review discusses the management of recurrent ischemic priapism, highlighting that various treatments show differing efficacy and side effect profiles but that more research is needed to refine these strategies.

This article argues that polysomnographic studies recommended for factitious leg ulcers in patients may be based on faulty assumptions about causality related to unusual sleep disorders.

This report describes a case of pneumonitis caused by metronidazole in a 42-year-old woman hospitalized with no known drug hypersensitivity.

This review discusses the proposed shift from PCOS to PMOS, emphasizing a comprehensive approach to diagnosis and management, but reports no new clinical results.

In this case report, a 25-year-old woman with VKHD experienced an unusual occurrence of vellus-like hair growth on her normally hairless palm, observed twice over two years, expanding the known integumentary manifestations of VKHD.

In this study, researchers observed that chronic stress affected wild-derived house mice differently by sex, with females showing less weight gain and distinct behavioral changes, while males exhibited higher hair corticosterone levels, suggesting divergent coping strategies and implications for sex-specific stress assessment protocols.

This study found that, among patients in Ismailia, Egypt, patchy alopecia areata was the most common form, with a significant positive correlation between the number of lesions and disease severity, and noted males predominantly affected by this condition.

This study reports that a patient with severe, treatment-resistant alopecia areata experienced sustained hair regrowth and emotional improvement over 24 months following individualized homeopathic treatment, suggesting homeopathy may be a viable therapeutic option when conventional treatments fail.

This study reported that etrasimod did not achieve significant improvements in hair regrowth for moderate to severe alopecia areata at 24 weeks, although it showed a dose-dependent trend and was safe and well-tolerated over 52 weeks.

This study of baricitinib in adults with severe alopecia areata found that after initial success, 10.9% of participants lost treatment response by Week 152. Factors like longer disease duration and severe baseline symptoms were more common in those losing response.

This case study reports on a 4-year-old girl who developed telogen effluvium, a type of hair loss, after experiencing anaphylactic reactions to cow's milk. The authors highlight this as the first documentation of anaphylaxis potentially triggering telogen effluvium due to physiologic stress.

This study found that among patients over 45 with lower urinary tract symptoms due to benign prostatic hyperplasia, those with androgenic alopecia had worse symptoms and higher testosterone levels than those without baldness.

This study found that among placebo-treated patients in the BRAVE-AA trials, the likelihood of spontaneous hair regrowth in untreated severe alopecia areata was low, with only a small percentage achieving significant scalp, eyebrow, or eyelash hair improvement over 36 weeks.

In this study, researchers identified subgroups of patients with severe alopecia areata treated with baricitinib who experienced early, gradual, or late hair regrowth, finding that response was influenced by baseline disease severity and duration of hair loss.

In patients with alopecia areata, this study found elevated levels of venous thromboembolism markers SFMC and F1 + 2 compared to healthy controls, potentially indicating an increased risk for this condition.

This case study describes a 36-year-old woman with a history of recurrent limb weakness linked to hypokalemia and later diagnosed with Cushing syndrome indicated by elevated cortisol levels and a pituitary mass, which was treated with surgery and radiosurgery.

This report highlights a case of a 35-year-old man developing alopecia universalis following alemtuzumab treatment for multiple sclerosis, suggesting potential links between this medication and drug-induced alopecia areata, though the genetic overlap of the conditions may also play a role.

This study found that prolonged tofacitinib treatment in adult Indian patients with moderate-to-severe alopecia areata was associated with a high regrowth rate, which varied with factors like age at disease onset and treatment duration.

This case report describes a 39-year-old hypertensive and obese patient experiencing telogen effluvium potentially linked to a previous moderate COVID-19 infection, emphasizing the need for awareness of late symptoms associated with the disease.

This study reported no evidence that clomipramine reduces overgrooming or improves hair regrowth in cats with psychogenic alopecia compared to untreated cats.

This narrative review explores the potential mechanisms linking telogen effluvium to SARS-CoV-2 infection but reports no new clinical findings.

This case report details a 27-year-old woman's diagnosis of systemic lupus erythematosus with immune-mediated intravascular haemolysis, which improved with steroid treatment.

The abstract for this research is not provided, so results or conclusions from this study are not available.

In this case study, a 69-year-old woman with pityriasis rubra pilaris developed a scarring alopecia with lichen-planopilaris-like features, which responded well to early treatment.

This case study describes a rare presentation of childhood lupus with recurrent pericardial effusion and cardiac tamponade that responded to glucocorticoid therapy.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.